Introduction 

• The global arteriovenous fistula (AVF) devices market is gaining strong momentum as the incidence of chronic kidney disease and end-stage renal disease continues to rise worldwide, driving sustained demand for reliable vascular access solutions in long-term hemodialysis care.
• Valued at approximately USD 379.6 million in 2025, the market is expected to nearly double and reach around USD 780.4 million by 2035, supported by a steady compound annual growth rate of about 7.4% over the forecast period, reflecting consistent adoption across hospitals and dialysis centers.
• Ongoing advancements in minimally invasive AVF creation technologies, growing preference for durable and infection-resistant access options, and expanding dialysis infrastructure in both developed and emerging economies are collectively shaping the long-term growth outlook of the global arteriovenous fistula devices market.

Ansoff Matrix – Global Arteriovenous Fistula (AVF) Devices Market

Market Penetration

• Strengthening presence in existing dialysis centers by promoting early AVF adoption as the preferred vascular access option for long-term hemodialysis.
• Competitive pricing strategies and bundled offerings to increase usage of AVF creation devices in high-volume renal care facilities.
• Enhancing clinician training and post-procedure support to improve success rates and encourage repeat procurement in mature markets.

Market Development

• Expanding AVF device adoption across emerging economies where dialysis infrastructure is rapidly growing due to rising chronic kidney disease prevalence.
• Targeting outpatient dialysis clinics and ambulatory surgical centers as new end-user segments beyond traditional hospital settings.
• Leveraging public–private partnerships and government-backed renal care programs to enter underserved regional markets.

Product Development

• Innovating minimally invasive and endovascular AVF creation devices to reduce surgical complexity, recovery time, and complication rates.
• Integrating imaging guidance and smart monitoring features to enhance precision, durability, and long-term patency of AVFs.
• Developing patient-specific and anatomically adaptive solutions to improve outcomes in complex or high-risk cases.

Diversification

• Entering adjacent vascular access segments, including grafts and catheter-assisted technologies, to build comprehensive dialysis access portfolios.
• Exploring digital health and remote monitoring solutions to support AVF maturation tracking and long-term access management.
• Collaborating with renal care technology providers to deliver integrated end-to-end dialysis access and management ecosystems.

Segment and Key Players – Global Arteriovenous Fistula (AVF) Devices Market

By Product Type

• Surgical AVF creation devices
• Endovascular AVF (eAVF) devices
• AVF maturation and accessory devices

By Technique

• Conventional surgical AVF creation
• Minimally invasive / endovascular AVF creation

By End User

• Hospitals
• Dialysis centers
• Ambulatory surgical centers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

By Country (Regional Markets)

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• United Arab Emirates
• South Africa
• Rest of Middle East & Africa

Key Players – Global Arteriovenous Fistula (AVF) Devices Market (Cumulative List)

• Becton, Dickinson and Company (BD)
• Medtronic plc
• Teleflex Incorporated
• Merit Medical Systems, Inc.
• Fresenius Medical Care AG & Co. KGaA
• Getinge AB
• Terumo Corporation
• Cook Medical
• AngioDynamics, Inc.
• Avenu Medical, Inc.
• W. L. Gore & Associates, Inc.
• Boston Scientific Corporation
• Nipro Corporation
• Medikit Co., Ltd.